Jung Hyun Kwon, Si Hyun Bae, Jung Pil Suh, Ho Sung Park, Chan Ran You, Jong Young Choi, Seung Kew Yoon, Dong Hoon Lee, Ho Jong Chun, Byung Gil Choi, Chan Kwon Chung, Eun Sun Jung, Mi Ryung Ryu
Journal of the Korean Liver Cancer Study Group. 2007;7(1):49-54. Published online June 30, 2007
A 43 year-old-women patient was admitted for one month of jaundice. She was diagnosed hepatitis B carrier
17 years ago and has not done a routine check. Abdominal CT showed a large ill defined mass in left hepatic lobe
with inhomogenous enhancement in arterial and delayed phase. The result of biopsy including the
immunohistochemical stains showed the combined hepatocellular and cholangiocarcinoma (stage IVa, type C by
Allen and Lisa). With the radiation therapy (3,910 cGy), six times of transarterial chemo-lipiodolization and two
times of percutaneous ethanol injection, huge mass was markedly decreased in size and no stain in hepatic
angiogram. She underwent left lobectomy.
Combined hepatocellular and cholangiocarcinoma (cHCC-CC) is an uncommon form of primary liver cancer
having features of both hepatocellular and billiary epithelial differentiation. We report a case of cHCC-CC in a
patient who was serologically positive for hepatitis B virus. A 39-year-old male was diagnosed by
ultrasonography with an asymptomatic tumor in the left lobe of the liver. Based on radiologic and serologic
findings of elevated serum alpha-fetoprotein level, a preoperative diagnosis of hepatocellular carcinoma was made,
but differential diagnosis included focal nodular hyperplasia, because tumor was enhanced in delayed phase in
Godolinium MRI scan. A final diagnosis of cHCC-CC was made after operation.
Woo Jin Chung, Sang Hun Jeon, Dong Choon Kim, Ju Yup Lee, Kyung In Lee, Hye Jin Seo, Byung Kuk Jang, Kyung Sik Park, Kwang Bum Cho, Jae Seok Hwang, Sung Hoon Ahn, Ku Jeong Kang, Young Hoon Kim, Jung Hyeok Kweon, Young Hwan Kim, Yu Na Kang
Journal of the Korean Liver Cancer Study Group. 2007;7(1):59-61. Published online June 30, 2007
A 51 years-old man who had postnecrotic liver cirrhosis due to chronic hepatitis B had elevated serum alpha
fetoprotein level. According to computed tomographic findings, about 2.4cm sized mass was noted at segment 7
and he underwent segmentectomy. After 9 months later, multicentric recurrence was detected at segment 5-6, So,
he underwent transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection therapy. After
22 months later, marginal recurrence was noted again at segment 6. So, he underwent 2nd TACE and he was
following up over 30 months until now.